M D Crowell

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi request reprint Symptom reporting by functional dyspeptics during the water load test
    Michael P Jones
    Division of Gastroenterology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611 2908, USA
    Am J Gastroenterol 100:1334-9. 2005
  2. doi request reprint Gut microbiota and its possible relationship with obesity
    John K DiBaise
    Division of Gastroenterology and Hepatology, Mayo Clinic, 13400 E Shea Blvd, Scottsdale, AZ 85259, USA
    Mayo Clin Proc 83:460-9. 2008
  3. pmc Comparison of morning versus afternoon cecal intubation rates
    Christopher D Wells
    Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ 85259, USA
    BMC Gastroenterol 7:19. 2007
  4. ncbi request reprint New insights into the pathophysiology of irritable bowel syndrome: implications for future treatments
    Michael D Crowell
    Division of Gastroenterology and Hepatology, Mayo Clinic Scottsdale, 13400 E Shea Boulevard, Scottsdale, AZ 85259, USA
    Curr Gastroenterol Rep 7:272-9. 2005
  5. pmc Role of serotonin in the pathophysiology of the irritable bowel syndrome
    Michael D Crowell
    Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Mayo Foundation, 13400 E Shea Boulevard, Scottsdale, AZ 85259, U S A
    Br J Pharmacol 141:1285-93. 2004
  6. ncbi request reprint Enterochromaffin cells and 5-HT signaling in the pathophysiology of disorders of gastrointestinal function
    Michael D Crowell
    Mayo Foundation and Mayo Clinic, GI Physiology and Motility, Division of Gastroenterology and Hepatology, 13400 E Shea Blvd, Scottsdale, AZ 85259, USA
    Curr Opin Investig Drugs 5:55-60. 2004
  7. ncbi request reprint Antidepressants in the treatment of irritable bowel syndrome and visceral pain syndromes
    Michael D Crowell
    Division of Gastroenterology, Mayo Clinic College of Medicine and Mayo Foundation, Scottsdale, AZ 85259, USA
    Curr Opin Investig Drugs 5:736-42. 2004
  8. ncbi request reprint Activation of type-2 chloride channels: a novel therapeutic target for the treatment of chronic constipation
    Michael D Crowell
    Mayo Clinic Scottsdale, Division of Gastroenterology and Hepatology, 13400 East Shea Blvd, Scottsdale, AZ 85259, USA
    Curr Opin Investig Drugs 8:66-70. 2007
  9. ncbi request reprint Emerging drugs for chronic constipation
    Michael D Crowell
    Mayo Clinic, Mayo Clinic College of Medicine, Division of Gastroenterology, Scottsdale, 13400 East Shea Blvd, Scottsdale, AZ 85259, USA
    Expert Opin Emerg Drugs 14:493-504. 2009
  10. ncbi request reprint Subtypes of anal incontinence associated with bowel dysfunction: clinical, physiologic, and psychosocial characterization
    M D Crowell
    Clinical Enteric Neuroscience Translational and Epidemiologic Research CENTER Program, Mayo Foundation and Mayo Clinic, Rochester, Minnesota, USA
    Dis Colon Rectum 47:1627-35. 2004

Collaborators

Detail Information

Publications53

  1. ncbi request reprint Symptom reporting by functional dyspeptics during the water load test
    Michael P Jones
    Division of Gastroenterology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611 2908, USA
    Am J Gastroenterol 100:1334-9. 2005
    ..To better understand the role of these factors in symptom reporting, somatization, somatosensory amplification, alexithymia, and depression were evaluated in patients with functional dyspepsia undergoing a water load test...
  2. doi request reprint Gut microbiota and its possible relationship with obesity
    John K DiBaise
    Division of Gastroenterology and Hepatology, Mayo Clinic, 13400 E Shea Blvd, Scottsdale, AZ 85259, USA
    Mayo Clin Proc 83:460-9. 2008
    ..Existing evidence warrants further investigation of the microbial ecology of the human gut and points to modification of the gut microbiota as one means to treat people who are over-weight or obese...
  3. pmc Comparison of morning versus afternoon cecal intubation rates
    Christopher D Wells
    Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ 85259, USA
    BMC Gastroenterol 7:19. 2007
    ..We sought to examine any difference in cecal intubation rates between morning and afternoon colonoscopies and identify factors contributing to a discrepancy...
  4. ncbi request reprint New insights into the pathophysiology of irritable bowel syndrome: implications for future treatments
    Michael D Crowell
    Division of Gastroenterology and Hepatology, Mayo Clinic Scottsdale, 13400 E Shea Boulevard, Scottsdale, AZ 85259, USA
    Curr Gastroenterol Rep 7:272-9. 2005
    ..Increasingly novel mechanisms are being identified that should aid in better understanding of the complex pathophysiology of IBS and developing new therapies...
  5. pmc Role of serotonin in the pathophysiology of the irritable bowel syndrome
    Michael D Crowell
    Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Mayo Foundation, 13400 E Shea Boulevard, Scottsdale, AZ 85259, U S A
    Br J Pharmacol 141:1285-93. 2004
    ..5-HT modulates sensation and perception of visceral stimulation at peripheral and central sites. Therapeutic agents targeting altered 5-HT signalling may provide new, effective treatments for patients with IBS...
  6. ncbi request reprint Enterochromaffin cells and 5-HT signaling in the pathophysiology of disorders of gastrointestinal function
    Michael D Crowell
    Mayo Foundation and Mayo Clinic, GI Physiology and Motility, Division of Gastroenterology and Hepatology, 13400 E Shea Blvd, Scottsdale, AZ 85259, USA
    Curr Opin Investig Drugs 5:55-60. 2004
    ..Evidence is beginning to link disturbed 5-HT physiology with the pathophysiology of diarrhea and constipation in IBS, and with slow-transit constipation. This review discusses the current evidence on the pathobiology of these systems...
  7. ncbi request reprint Antidepressants in the treatment of irritable bowel syndrome and visceral pain syndromes
    Michael D Crowell
    Division of Gastroenterology, Mayo Clinic College of Medicine and Mayo Foundation, Scottsdale, AZ 85259, USA
    Curr Opin Investig Drugs 5:736-42. 2004
    ..The newer generation antidepressants may provide additional insight into the pathophysiology of the brain-gut interactions and their relationship to functional bowel disorders, providing new therapeutic interventions...
  8. ncbi request reprint Activation of type-2 chloride channels: a novel therapeutic target for the treatment of chronic constipation
    Michael D Crowell
    Mayo Clinic Scottsdale, Division of Gastroenterology and Hepatology, 13400 East Shea Blvd, Scottsdale, AZ 85259, USA
    Curr Opin Investig Drugs 8:66-70. 2007
    ..The predominant adverse effects were nausea and diarrhea. Lubiprostone represents a new therapeutic class of compounds for the treatment of chronic constipation and will be the focus of this review...
  9. ncbi request reprint Emerging drugs for chronic constipation
    Michael D Crowell
    Mayo Clinic, Mayo Clinic College of Medicine, Division of Gastroenterology, Scottsdale, 13400 East Shea Blvd, Scottsdale, AZ 85259, USA
    Expert Opin Emerg Drugs 14:493-504. 2009
    ..CC may be influenced by genetic predisposition, environmental factors and stress. In this article, the safety and efficacy of traditional and emerging therapies for CC are examined...
  10. ncbi request reprint Subtypes of anal incontinence associated with bowel dysfunction: clinical, physiologic, and psychosocial characterization
    M D Crowell
    Clinical Enteric Neuroscience Translational and Epidemiologic Research CENTER Program, Mayo Foundation and Mayo Clinic, Rochester, Minnesota, USA
    Dis Colon Rectum 47:1627-35. 2004
    ..We hypothesized that functional anal incontinence with no structural explanation comprises distinct pathophysiologic subgroups that could be identified on the basis of the predominant presenting bowel pattern...
  11. ncbi request reprint The effects of tegaserod, a 5-HT receptor agonist, on gastric emptying in a murine model of diabetes mellitus
    M D Crowell
    The Marvin M Schuster Center for Digestive and Motility Disorders, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Neurogastroenterol Motil 17:738-43. 2005
    ..We assessed gastric emptying rates in C57BLKS/J mice, and determined the effects of tegaserod, a new selective 5-HT(4) receptor partial agonist, on gastric emptying...
  12. ncbi request reprint Obesity is associated with increased 48-h esophageal acid exposure in patients with symptomatic gastroesophageal reflux
    Michael D Crowell
    Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, Arizona, USA
    Am J Gastroenterol 104:553-9. 2009
    ..We hypothesized that overweight (OW) and obese (OB) patients with GER symptoms would have a higher degree of esophageal acid exposure than with normal weight (NW) patients...
  13. doi request reprint An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus
    A Das
    Division of Gastroenterology and Hepatology, Mayo Clinic Arizona, Scottsdale, AZ 85259, USA
    Endoscopy 41:400-8. 2009
    ..The aim of the current study was to perform an economic analysis evaluating the cost-effectiveness of endoscopic ablation of nondysplastic Barrett's esophagus...
  14. doi request reprint Functional dyspepsia: the economic impact to patients
    B E Lacy
    Division of Gastroenterology and Hepatology, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA
    Aliment Pharmacol Ther 38:170-7. 2013
    ..Although highly prevalent, little is known about the economic impact of functional dyspepsia (FD)...
  15. ncbi request reprint Brain-gut connections in functional GI disorders: anatomic and physiologic relationships
    M P Jones
    Division of Gastroenterology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
    Neurogastroenterol Motil 18:91-103. 2006
    ....
  16. ncbi request reprint The effect of feeding on defecation behaviour in pigs
    F Musial
    Department of Medicine and Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD
    Physiol Behav 51:643-6. 1992
    ..These results suggest that eating lowers defecation threshold in terms of distention volume and rectal pressure, and that these changes are not dependent on altered rectal compliance or changes in distention induced motor activity...
  17. ncbi request reprint The effects of an inhaled beta(2)-adrenergic agonist on lower esophageal function: a dose-response study
    M D Crowell
    Marvin M. Schuster Center for Digestive and Motility Disorders, The Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
    Chest 120:1184-9. 2001
    ..Inhaled beta(2)-agonists may increase the likelihood of acid reflux in a subset of patients who receive cumulative dosing...
  18. ncbi request reprint Generalized intestinal dysmotility in a patient with syringomyelia
    B E Lacy
    The Marvin M. Schuster Center for Digestive and Motility Disorders, The Johns Hopkins Bayview Medical Center, Baltimore, Maryland 21224, USA
    Am J Gastroenterol 96:1282-5. 2001
    ..This report highlights the need for more objective studies of gastrointestinal motility in patients with syringomyelia...
  19. ncbi request reprint Novel partial 5HT3 agonist pumosetrag reduces acid reflux events in uninvestigated GERD patients after a standard refluxogenic meal: a randomized, double-blind, placebo-controlled pharmacodynamic study
    R S Choung
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA Division of Gastroenterology and Hepatology, Korea University College of Medicine, Korea University, Seoul, South Korea
    Neurogastroenterol Motil 26:13-20. 2014
    ..We aimed to evaluate the effect of pumosetrag on changes in reflux episodes, lower esophageal sphincter pressure (LESP), and specific symptoms in patients with GERD receiving a refluxogenic meal...
  20. doi request reprint Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies
    Q Wu
    College of Medicine, Mayo Clinic, 13400 E Shea Blvd, Scottsdale, AZ 85259, USA
    Osteoporos Int 23:365-75. 2012
    ..This meta-analysis, which pooled results from 13 qualifying cohort and case-control studies, found that SSRIs were associated with a significantly increased risk of fractures...
  21. ncbi request reprint Observational study of the frequency of use and perceived usefulness of ancillary manoeuvres to facilitate colonoscopy completion
    S L Hansel
    Department of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ, United States
    Dig Liver Dis 41:812-6. 2009
    ..This information would be useful to understand and improve colonoscopy technique...
  22. ncbi request reprint Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis
    S Wessinger
    Division of Gastroenterology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
    Aliment Pharmacol Ther 23:937-44. 2006
    ..Various bleeding complications have been reported in persons taking SSRIs including an increased risk of gastrointestinal haemorrhage (GIH)...
  23. ncbi request reprint Inflammatory causes of gastroparesis: report of five cases
    H Pande
    Marvin M Schuster Center for Digestive and Motility Disorders, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA
    Dig Dis Sci 47:2664-8. 2002
  24. ncbi request reprint Patient characteristics, clinical, endoscopic, and histologic findings in adult eosinophilic esophagitis: a case series and systematic review of the medical literature
    S F Pasha
    Division of Gastroenterology and Hepatology, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA
    Dis Esophagus 20:311-9. 2007
    ....
  25. ncbi request reprint Influences of pelvic floor structures and sacral innervation on the response to distension of the cat rectum
    Carole Mathis
    MM Schuster Center for Digestive and Motility Disorders, Johns Hopkins University, Baltimore, MD, USA
    Neurogastroenterol Motil 14:265-70. 2002
    ..Afferent inputs and spinal autonomic reflexes may decrease the tone of the rectal musculature during distension...
  26. ncbi request reprint 5-HT and the brain-gut axis: opportunities for pharmacologic intervention
    Michael D Crowell
    Expert Opin Investig Drugs 16:761-5. 2007
    ..In this editorial, recent data are reviewed and the potential for the development of pharmacologic intervention is assessed...
  27. ncbi request reprint Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome
    Matthew D Coates
    Department of Anatomy and Neurobiology, University of Vermont College of Medicine, Burlington, VT 05405, USA
    Gastroenterology 126:1657-64. 2004
    ..Our aim was to test whether enteric 5-HT signaling is defective in these disorders...
  28. ncbi request reprint Regional gastric contractility alterations in a diabetic gastroparesis mouse model: effects of cholinergic and serotoninergic stimulation
    Arlene N James
    Department of Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA
    Am J Physiol Gastrointest Liver Physiol 287:G612-9. 2004
    ..This study suggests that fundic hypomotility and pyloric hypercontractility, rather than antral hypomotility, play important roles for the gastric dysmotility that occurs in diabetes...
  29. pmc Increased colonic pain sensitivity in irritable bowel syndrome is the result of an increased tendency to report pain rather than increased neurosensory sensitivity
    Spencer D Dorn
    Center for Functional GI and Motility Disorders, University of North Carolina, Campus Box 7080, Chapel Hill, NC 27599 7080, USA
    Gut 56:1202-9. 2007
    ..The aim was to determine whether lower visceral pain thresholds in irritable bowel syndrome (IBS) primarily reflect physiological or psychological factors...
  30. ncbi request reprint Linaclotide, a new direction in the treatment of irritable bowel syndrome and chronic constipation
    Lucinda A Harris
    Mayo Clinic School of Medicine, Division of Gastroenterology and Hepatology, 13400 East Shea Blvd, Scottsdale, AZ 85259, USA
    Curr Opin Mol Ther 9:403-10. 2007
    ..Phase II clinical trials are underway for both indications...
  31. ncbi request reprint The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus
    Brian E Lacy
    Marvin M Schuster Center for Digestive and Motility Disorders, Johns Hopkins University, School of Medicine, Baltimore, MD, USA
    Diabetes Care 27:2341-7. 2004
    ....
  32. ncbi request reprint Nausea, bloating and abdominal pain in the Roux-en-Y gastric bypass patient: more questions than answers
    G Anton Decker
    Division of Gastroenterology and Hepatology, Mayo Clinic, 13400 East Shea Blvd, Scottsdale, AZ 85259, USA
    Obes Surg 17:1529-33. 2007
    ..Options are discussed for examining the excluded segment, and the diagnosis and significance of small intestine bacterial overgrowth in the RYGBP patient is reviewed...
  33. ncbi request reprint Psychosocial correlates of symptoms in functional dyspepsia
    Michael P Jones
    Division of Gastroenterology, Mayo Clinic, Scottsdale, AZ, USA
    Clin Gastroenterol Hepatol 3:521-8. 2005
    ..We determined the presence and severity of these factors as well as their relationship to dyspeptic symptoms in patients with functional dyspepsia and healthy subjects...
  34. ncbi request reprint Coping strategies and interpersonal support in patients with irritable bowel syndrome and inflammatory bowel disease
    Michael P Jones
    Division of Gastroenterology and Hepatology, Northwestern University Medical School, Chicago, Illinois, USA
    Clin Gastroenterol Hepatol 4:474-81. 2006
    ..To understand their role better, coping strategies, social support, and psychiatric distress were assessed in patients with IBS and IBD and in controls...
  35. ncbi request reprint Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea
    Nicholas J Talley
    Mayo Foundation, Mayo Medical School, Rochester, Minnesota 55905, USA
    Am J Gastroenterol 98:2454-9. 2003
    ..We aimed to determine and to compare the distribution of GI symptoms, both, upper and lower, among IBS-C and IBS-D patients...
  36. ncbi request reprint Pathogenesis of slow transit and pelvic floor dysfunction: from bench to bedside
    Michael D Crowell
    Functional Neuroenteric Group, Mayo Clinic College of Medicine, Scottsdale, Arizona, USA
    Rev Gastroenterol Disord 4:S17-27. 2004
    ..These mechanisms and their relative importance to the pathogenesis of slow-transit constipation and pelvic floor dysfunction will be reviewed...
  37. ncbi request reprint Relationship of bloating to other GI and menstrual symptoms in women with irritable bowel syndrome
    Margaret M Heitkemper
    Department of Biobehavioral Nursing and Health Systems, University of Washington, Seattle, Washington, USA
    Dig Dis Sci 49:88-95. 2004
    ..In conclusion, bloating is a very common symptom in women with IBS that is most strongly related to abdominal pain and intestinal gas but may be confounded with menses-associated symptoms...
  38. ncbi request reprint Gastrointestinal and nutritional complications after bariatric surgery
    G Anton Decker
    Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, Arizona 85259, USA
    Am J Gastroenterol 102:2571-80; quiz 2581. 2007
    ..We review the most common gastrointestinal and nutritional complications after bariatric procedures and examine how gastroenterologists may best prevent, investigate, and treat them...
  39. ncbi request reprint Botulinum toxin for the treatment of gastroparesis: a preliminary report
    Brian E Lacy
    The Division of Digestive Disease and the Marvin M Schuster Center for Digestive and Motility Disorders, John Hopkins Bayview Medical Center, Baltimore, Maryland 21224, USA
    Am J Gastroenterol 97:1548-52. 2002
    ..Possible mechanisms of action of botulinum toxin on the pylorus and its effects in patients with gastroparesis are discussed...
  40. ncbi request reprint Case report: botulinum toxin in hypertensive lower esophageal sphincter: a manometric case study
    Brian E Lacy
    The Marvin M Schuster Center for Gastrointestinal Motility and Digestive Disorders, Johns Hopkins Bayview Medical Center, Baltimore, Maryland 21224, USA
    Dysphagia 17:75-80. 2002
    ..Current pathophysiologic hypotheses for HLES-associated dysphagia and its treatment are briefly reviewed in this report...
  41. ncbi request reprint Behavioral intervention for the treatment of obesity: strategies and effectiveness data
    Rona L Levy
    University of Washington, Seattle, Washington, USA
    Am J Gastroenterol 102:2314-21. 2007
    ..Gastroenterologists are encouraged to use it as a first line of treatment for most obese patients, and as a key component of therapies that involve pharmacologic and surgical components...
  42. ncbi request reprint Age, specialty, and practice setting predict gastroesophageal reflux disease prescribing behavior
    Brian E Lacy
    Marvin M Schuster Center for Digestive and Motility Disorders, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Clin Gastroenterol 39:489-94. 2005
    ..This study was undertaken to determine physician prescribing practices in the treatment of GERD...
  43. ncbi request reprint The association of gastrointestinal symptoms with weight, diet, and exercise in weight-loss program participants
    Rona L Levy
    University of Washington, Seattle, Washington 98105, USA
    Clin Gastroenterol Hepatol 3:992-6. 2005
    ..This study assessed rates of GI symptoms in a sample of obese patients in a weight-loss program and explored relationships among GI symptoms and obesity, binge eating, dieting (fat and fruit/fiber consumption), and physical activity...
  44. ncbi request reprint Cilansetron
    Kevin W Olden
    Division of Gastroenterology, University of South Alabama, Mobile, Alabama 36693, USA
    Drugs Today (Barc) 41:661-6. 2005
    ....
  45. ncbi request reprint Severe chest pain from an indwelling Bravo pH probe
    Stuart L Triester
    Gastrointest Endosc 61:317-9. 2005
  46. ncbi request reprint Physicians' attitudes and practices in the evaluation and treatment of irritable bowel syndrome
    Brian E Lacy
    Department of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire 03756, USA
    Scand J Gastroenterol 41:892-902. 2006
    ....
  47. ncbi request reprint Irritable bowel syndrome and chronic constipation: emerging drugs, devices, and surgical treatments
    Lucinda A Harris
    Division of Gastroenterology, Mayo Clinic, Scottsdale, AZ 85259, USA
    Curr Gastroenterol Rep 8:282-90. 2006
    ..In this article, the safety and efficacy of traditional and emerging therapies for CC and IBS are examined. In addition, their pathophysiology and symptoms are briefly reviewed...
  48. ncbi request reprint Gut-brain neuropeptides in the regulation of ingestive behaviors and obesity
    Michael D Crowell
    The Mayo Clinic College of Medicine, Scottsdale, Arizona 85259, USA
    Am J Gastroenterol 101:2848-56; quiz 2914. 2006
    ..Gut-brain peptides may provide attractive therapeutic targets in the fight against this very morbid disease. We review alterations in GI function and some of the more important gut-brain neuropeptides that occur in obesity...
  49. ncbi request reprint Impact of anal incontinence on psychosocial function and health-related quality of life
    Michael D Crowell
    The Marvin M Schuster Center for Digestive and Motility Disorders, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA
    Dig Dis Sci 52:1627-31. 2007
    ..AI was associated with impaired psychosocial function and decreased HRQOL. The frequency of AI was associated with increased HRQOL-Interference, but minimally with the degree of psychosocial impairment...
  50. ncbi request reprint Functional gastrointestinal disorders: an update for the psychiatrist
    Michael P Jones
    Feinberg School of Medicine, Northwestern University, Chicago, IL 60611 2908, USA
    Psychosomatics 48:93-102. 2007
    ..Finally, there is a need for greater involvement of psychiatrists in both the evaluation and treatment of patients with FGID as well as the education and training of practitioners caring for these patients...
  51. ncbi request reprint High-resolution manometry in the evaluation of anorectal disorders: a simultaneous comparison with water-perfused manometry
    Michael P Jones
    Division of Gastroenterology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
    Am J Gastroenterol 102:850-5. 2007
    ..This preliminary feasibility study is the first report evaluating HRM and simultaneously performed water-perfused manometry (WPM) in patients referred for anorectal manometry (ARM)...
  52. ncbi request reprint Editorial overview: serotonergic agents in functional GI disorders: targeting the brain-gut axis
    Sarah Wessinger
    Curr Opin Investig Drugs 6:663-6. 2005
  53. ncbi request reprint Patient knowledge and perspective on irritable bowel syndrome: development of a survey instrument
    Kirsten Teaney Weiser
    Division of Gastroenterology and Hepatology, Area 4C, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA
    Dig Dis Sci 53:284-95. 2008
    ..The aims of this study were to operationalize the constructs used by patients to understand their symptoms and to develop a reliable, validated questionnaire...